FANCD2 and neoplasm: Surprisingly, this new revelation may indicate that the long-known form of FANCD2, V1, might be somewhat “oncogenic” owing to its relatively high expression levels in malignant cells/tissues, in conjunction with inefficient tumor suppressive activity compared to V2.